Drugs 2012; 72 (11): 1578 0012-6667/12/0011-1578

ERRATUM

Adis ª 2012 Springer International Publishing AG. All rights reserved.

Article corrected Keating GM. Azacitidine: a review of its use in the management of myelodysplastic syndromes/acute myeloid leukaemia. Drugs 2012; 72 (8): 1111-1136 Correction Made Page 1125, column 2, paragraph 2, lines 5-9: The following sentence, which previously read: ‘‘In the Japanese trial, nadir haemoglobin and platelet levels were reached in a median of 17 days, and the nadir absolute plalelet count was reached in a median of 25 days.[37]’’ has now been corrected as follows: ‘‘In the Japanese trial, nadir haemoglobin and platelet levels were reached in a median of 17 days, and the nadir absolute neutrophil count was reached in a median of 25 days.[37]’’ Note All online versions of this article have been updated to reflect this correction.